Key Highlights

● BG closed at $102.69 on 9 October 2026, and the $129.33 consensus target implies upside of about 25.9%.

● The consensus draws on 11 analysts, with a stated range of $110 to $150, while the second data set shows a higher $141.78 mean from nine analysts.

● Market data records eight Buy and three Hold ratings with no Sell, a Moderate Buy consensus.

● UBS raised its Buy-rated target to $155 from $145 on 10 September, and BMO Capital Markets reiterated Outperform with a $150 target on 13 August.

Bunge Limited (NYSE:BG), a constituent of the S&P 500, closed at $102.69 on Friday 9 October 2026. Bunge is an agribusiness and food company, and analysts' published targets sit well above the current share price.

What Is the Latest Analyst Price Target?

Market data shows a consensus 12-month price target of $129.33 from 11 analysts, implying upside of about 25.9% from the $102.69 close. Its stated range runs from a low of $110 to a high of $150.

The second data set, using third-party data, shows a higher mean of $141.78 and a median of $140, with a range of $116 to $155 from nine analysts. Its price data were dated 29 September, when the shares were $108.14, and its targets were last updated on 10 September.

The data sets differ by about $12 on the mean. The figures also contain an inconsistency, because its high target of $150 is below a $155 UBS target that it lists separately.

What Are Wall Street Analysts Saying?

Market data records eight Buy and three Hold ratings, with no Sells, for a Moderate Buy consensus. The second data set counts five Strong Buy, three Buy and one Hold.

Named broker actions were limited. On 10 September 2026, UBS raised its target from $145 to $155 with a Buy rating. On 13 August, BMO Capital Markets reiterated an Outperform rating with a $150 target. Both recent named targets are above the market data consensus, which suggests the average includes lower, possibly older, estimates.

Market data also lists quantitative rating changes from independent ratings services, which are not traditional broker research: one moved from Strong-Buy to Hold on 7 September, and another reiterated Hold on 19 August.

What Could Help the Stock Reach the Price Target?

The gap between the share price and the named broker targets suggests analysts see scope for improvement in earnings. Agribusiness companies are often influenced by crop volumes, processing margins and demand for oilseeds, and a favourable move in these could support estimates.

What Could Prevent the Stock Reaching the Target?

The shares have fallen from the $108.14 the second data set recorded at the end of September to $102.69, which shows that sentiment can shift quickly. The ratings-service move to Hold also shows that not every rating source is positive.

Commodity prices, trade policy, weather, freight costs and currency movements can all affect agribusiness profits and may lead analysts to lower forecasts. Because both data sets' averages include analysts with different update dates, the headline consensus could change as new research is published.

What Should Investors Watch Next?

Following the next results, items to watch include whether analysts change their targets, whether the Hold ratings increase or decrease, and whether the two data sets' figures move closer together.

Bunge's Consensus Gap Rests on Few Named Broker Actions

Bunge closed at $102.69 on 9 October 2026, with the $129.33 consensus target about 25.9% higher and the second data set's $141.78 mean higher still, though that data set's price and targets date from late September and 10 September. Both recent named targets, UBS at $155 and BMO at $150, sit above the consensus, which suggests the average includes lower, possibly older estimates, and market data's $150 high is below UBS's $155, an inconsistency within its own figures. Ratings are mostly positive, but the evidence rests on a small number of named broker actions.